Mr Iomar Barrett, Celosia Therapeutics’ Series A investor and hedge fund manager, speaks about his investment philosophy as a biotech investor, and reasons why he invested in Celosia Therapeutics.
In this video, Mr Barrett discusses in-depth the current biotech investment landscape, more specifically the state of ALS research investment. He notes that the research done by Celosia Therapeutics forms a solid scientific foundation, along with a team that boasts clinical expertise, the company represents a true breakthrough.
This video was produced with the support of The Scott-Morgan Foundation, a leading philanthropic organisation using human-centric, AI-driven assistive solutions to support ALS/MND patients. An AI representation of Mr Barrett was created by the Foundation.